ALG 006746
Alternative Names: ALG-006746Latest Information Update: 13 Aug 2024
At a glance
- Originator Aligos Therapeutics
- Class Antivirals
- Mechanism of Action Capsid protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis B